Skip to content
Research To Practice | Oncology Videos cover art

All Episodes

Research To Practice | Oncology Videos — 1,000 episodes · page 1 of 10

#
Title
1

Metastatic Bladder Cancer — Rapid Case Review Issue 8

2

Metastatic Bladder Cancer — Rapid Case Review Issue 7

3

Breast Cancer — Reviewing Key Presentations from the 2026 ASCO Annual Meeting

4

Low-Grade Serous Ovarian Cancer — Rapid Case Review: Microlearning Activity 2

5

Low-Grade Serous Ovarian Cancer — 5-Minute Journal Club: Microlearning Activity 1

6

Chronic Myeloid Leukemia — An Interview with Prof Andreas Hochhaus

7

Chronic Myeloid Leukemia — An Interview with Prof Andreas Hochhaus (Companion Faculty Lecture)

8

Endometrial Cancer — Microlearning Activity 3: Proceedings from an Independent Satellite Symposium during the SGO Annual Meeting on Women's Cancer

9

Non-Small Cell Lung Cancer — Targeting KRAS G12C

10

Prostate Cancer — The Optimal Use of Hormonal Therapy

11

Chronic Lymphocytic Leukemia — Rapid Case Review: Microlearning Activity 4

12

Chronic Lymphocytic Leukemia — 5-Minute Journal Club: Microlearning Activity 3

13

AKT Inhibition in Prostate Cancer — Microlearning Activity 3: Proceedings from a Session Held Adjunct to the 2026 ASCO GU Cancers Symposium

14

ER-Positive, HER2-Positive Metastatic Breast Cancer — Patterns of Care Among Community Oncologists

15

Relapsed/Refractory Chronic Lymphocytic Leukemia — A Grand Rounds Program

16

Lambert-Eaton Myasthenic Syndrome in Small Cell Lung Cancer — An Interview with Prof Ticiana Leal (Companion Faculty Lecture)

17

Lambert-Eaton Myasthenic Syndrome in Small Cell Lung Cancer — An Interview with Prof Ticiana Leal

18

For Oncology Nurses: Prostate Cancer — Proceedings from the 2026 Annual ONS Congress

19

Metastatic Triple-Negative Breast Cancer — Patterns of Care

20

Non-Muscle-Invasive and Muscle-Invasive Bladder Cancer — Microlearning Activity 4: Proceedings from a Session Held Adjunct to the 2026 ASCO GU Cancers Symposium

21

Non-Muscle-Invasive and Muscle-Invasive Bladder Cancer — Microlearning Activity 3: Proceedings from a Session Held Adjunct to the 2026 ASCO GU Cancers Symposium

22

Non-Hodgkin Lymphoma — Year in Review Series on Relevant New Datasets and Advances

23

Non-Hodgkin Lymphoma | Sonali M Smith, MD

24

Non-Hodgkin Lymphoma | Matthew Matasar, MD

25

HR-Positive Metastatic Breast Cancer — Year in Review Series on Relevant New Datasets and Advances in the PI3K/AKT/mTOR Pathway

26

For Oncology Nurses: Pancreatic Cancer — Proceedings from the 2026 Annual ONS Congress

27

Targeting the PI3K/AKT/mTOR Pathway in HR-Positive Metastatic Breast Cancer | Hope S Rugo, MD

28

Targeting the PI3K/AKT/mTOR Pathway in HR-Positive Metastatic Breast Cancer | Virginia Kaklamani, MD, DSc

29

AKT Inhibition in Prostate Cancer — Microlearning Activity 2: Proceedings from a Session Held Adjunct to the 2026 ASCO GU Cancers Symposium

30

AKT Inhibition in Prostate Cancer — Microlearning Activity 1: Proceedings from a Session Held Adjunct to the 2026 ASCO GU Cancers Symposium

31

Gastroesophageal Cancers — Year in Review Series on Relevant New Datasets and Advances

32

Gastroesophageal Cancers | David H Ilson, MD, PhD

33

Gastroesophageal Cancers | Kohei Shitara, MD

34

Genitourinary Cancers — Reviewing Key Presentations from the 2026 ASCO Annual Meeting

35

For Oncology Nurses: Oral Selective Estrogen Receptor Degraders in Breast Cancer — Proceedings from the 2026 Annual ONS Congress

36

Metastatic Bladder Cancer — Rapid Case Review Issue 6

37

Metastatic Bladder Cancer — Rapid Case Review Issue 5

38

Multiple Myeloma — Year in Review Series on Relevant New Datasets and Advances

39

Multiple Myeloma | Robert Z Orlowski, MD, PhD

40

Multiple Myeloma | Amrita Krishnan, MD

41

Non-Muscle-Invasive and Muscle-Invasive Bladder Cancer — Microlearning Activity 2: Proceedings from a Session Held Adjunct to the 2026 ASCO GU Cancers Symposium

42

Non-Muscle-Invasive and Muscle-Invasive Bladder Cancer — Microlearning Activity 1: Proceedings from a Session Held Adjunct to the 2026 ASCO GU Cancers Symposium

43

Non-Hodgkin Lymphoma — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting on the Roles of CAR T-Cell Therapy and Bispecific Antibodies

44

Prostate Cancer — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting

45

Myelofibrosis — Proceedings from a Webinar Held in Conjunction with the 2026 ASCO Annual Meeting

46

For Oncology Nurses: Targeting the PI3K/AKT/mTOR Pathway in HR-Positive Metastatic Breast Cancer — Proceedings from the 2026 Annual ONS Congress

47

Small Cell Lung Cancer — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting

48

Gastroesophageal Cancers — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting

49

Chronic Lymphocytic Leukemia — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting

50

Non-Small Cell Lung Cancer — Year in Review Series on Relevant New Datasets and Advances in Therapeutic Targets Beyond EGFR

51

Therapeutic Targets Beyond EGFR for Non-Small Cell Lung Cancer | Maurice Pérol, MD

52

Therapeutic Targets Beyond EGFR for Non-Small Cell Lung Cancer | John V Heymach, MD, PhD

53

For Oncology Nurses: Relapsed/Refractory Multiple Myeloma — Proceedings from the 2026 Annual ONS Congress

54

TROP2- and CDH6-Directed ADCs in Gynecologic Cancers — An Interview with Dr Ramez Eskander on Key Presentations from the Society of Gynecologic Oncology 2026 Annual Meeting

55

HER2-Altered Non-Small Cell Lung Cancer — 5-Minute Journal Club: Microlearning Activity 3

56

HER2-Altered Non-Small Cell Lung Cancer — 5-Minute Journal Club: Microlearning Activity 2

57

For Oncology Nurses: CDK4/6 Inhibitors for Breast Cancer — Proceedings from the 2026 Annual ONS Congress

58

Colorectal Cancer — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting

59

Chronic Lymphocytic Leukemia — 5-Minute Journal Club: Microlearning Activity 1

60

Chronic Lymphocytic Leukemia — Rapid Case Review: Microlearning Activity 2

61

Breast Cancer — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting on the Use of Oral SERDs and Agents Targeting the PI3K/AKT/mTOR Pathway

62

For Oncology Nurses: Ovarian Cancer — Proceedings from the 2026 Annual ONS Congress

63

Relapsed/Refractory Multiple Myeloma — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting

64

EGFR-Mutated Non-Small Cell Lung Cancer — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting

65

Endometrial Cancer — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting

66

HER2-Positive Metastatic Breast Cancer — An Interview with Prof Dr Sibylle Loibl on First-Line and Maintenance Therapy

67

HER2-Positive Metastatic Breast Cancer — An Interview with Prof Dr Sibylle Loibl on First-Line and Maintenance Therapy (Companion Faculty Lecture)

68

For Oncology Nurses: Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia — Proceedings from the 2026 Annual ONS Congress

69

Ovarian Cancer — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting

70

HER2-Altered Non-Small Cell Lung Cancer — Rapid Case Review

71

Localized HR-Positive Breast Cancer — Year in Review Series on Relevant New Datasets and Advances

72

Localized HR-Positive Breast Cancer | Joyce O'Shaughnessy, MD

73

Localized HR-Positive Breast Cancer | Harold J Burstein, MD, PhD

74

Endometrial Cancer — Microlearning Activity 2: Proceedings from an Independent Satellite Symposium during the SGO Annual Meeting on Women's Cancer

75

Nonmetastatic Non-Small Cell Lung Cancer — An Interview with Dr Jamie E Chaft

76

Endometrial Cancer — Microlearning Activity 1: Proceedings from an Independent Satellite Symposium during the SGO Annual Meeting on Women's Cancer

77

Novel Therapies for Non-Hodgkin Lymphoma — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting

78

Antibody-Drug Conjugates in the Management of Breast Cancer — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting

79

Endometrial Cancer — An Interview with Dr Floor J Backes

80

For Oncology Nurses: Strategies to Safely and Effectively Implement Antibody-Drug Conjugates — Proceedings from the 2026 Annual ONS Congress

81

Androgen Deprivation Therapy for Prostate Cancer — An Interview with Dr Rana R McKay

82

Androgen Deprivation Therapy for Prostate Cancer — An Interview with Dr Rana R McKay (Companion Faculty Lecture)

83

For Oncology Nurses: Non-Muscle-Invasive and Muscle-Invasive Bladder Cancer — Proceedings from the 2026 Annual ONS Congress

84

Targeted Therapies for Non-Small Cell Lung Cancer — Fifth Annual National General Medical Oncology Summit

85

HR-Positive Breast Cancer — Fifth Annual National General Medical Oncology Summit

86

Acute Myeloid Leukemia — Fifth Annual National General Medical Oncology Summit

87

Desmoid Tumors and Soft Tissue Sarcoma — Fifth Annual National General Medical Oncology Summit

88

EGFR-Mutated Non-Small Cell Lung Cancer — Fifth Annual National General Medical Oncology Summit

89

Metastatic Triple-Negative Breast Cancer — What Clinicians Want to Know

90

Urothelial Bladder Cancer | Thomas Powles, MBBS, MRCP, MD

91

Urothelial Bladder Cancer | Ashish M Kamat, MD, MBBS

92

Urothelial Bladder Cancer — Year in Review Series on Relevant New Datasets and Advances

93

For Oncology Nurses: Endometrial Cancer — Proceedings from the 2026 Annual ONS Congress

94

Myelofibrosis and Systemic Mastocytosis — Fifth Annual National General Medical Oncology Summit

95

Prostate Cancer — Fifth Annual National General Medical Oncology Summit

96

HER2-Positive Breast Cancer — Fifth Annual National General Medical Oncology Summit

97

Colorectal Cancer — Fifth Annual National General Medical Oncology Summit

98

Triple-Negative Breast Cancer — Fifth Annual National General Medical Oncology Summit

99

Desmoid Tumors — Microlearning Activity 4 with Prof Bernd Kasper

100

Ovarian Cancer — Fifth Annual National General Medical Oncology Summit